As of 2026-04-03, the Relative Valuation of Gemina Laboratories Ltd (GLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.04 CAD, the upside of Gemina Laboratories Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2026-02-24 | -0.78 |
| 2026-01-07 | -1.18 |
| 2025-12-31 | -1.18 |
| 2025-12-30 | -1.18 |
| 2025-12-29 | -1.96 |
| 2025-12-22 | -1.57 |